why choose us

Clinical Trials Search

Showing 15,530 of 132,963 result(s)
Chronic Non-Specific Neck Pain Treated With Tai Chi and Chiropractic Care

Status: Completed

Condition: Neck Pain

Interventions: Chiropractic care will be delivered by community-based chiropractors that meet pre-set qualifications.
Chiropractic treatment protocol will be mu

Date: 2023-02-03

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

Status: Completed

Condition: Overweight and Obesity

Interventions: Healthi refers to the Healthi app, which is a mobile application for weight loss

Date: 2023-02-03

Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia

Status: ACTIVE_NOT_RECRUITING

Condition: Dementia

Interventions: This is one-arm, health-system embedded pragmatic pilot trial

Date: 2023-02-03

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants

Status: Completed

Condition: Healthy Volunteers

Interventions: E2025 IV infusion.

Date: 2023-02-03

Effect of Alpelisib in Healthy Volunteers

Status: COMPLETED

Condition: Insulin Resistance

Interventions: Participants will ingest two overencapsulated tablets of alpelisib at 23:00, along with a saltine cracker.

Date: 2023-02-03

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

Status: Completed

Condition: Paroxysmal Supraventricular Tachycardia

Interventions:

Part 1A: At least 12 patients will be administered with Etripamil NS (35 mg;100 ?L per nostril) at a dose of 70 mg.

Part 1B: At least 18

Date: 2023-02-03

A Study of ELI-002 7P in Subjects With KRAS;NRAS Mutated Solid Tumors

Status: Completed

Condition: Pancreatic Ductal Adenocarcinoma

Interventions: ELI-002 Amph-CpG-7909 admixed with ELI-002 Amph-Peptides 7P administered via SC injection weekly for 4 consecutive weeks, followed by bi-weekly inject

Date: 2023-02-03

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

Status: Completed

Condition: Primary Progressive Aphasia

Interventions: Participants with nonfluent;agrammatic variant primary progressive aphasia (PPA) or a predominantly nonfluent profile work on producing personall

Date: 2023-02-03

Supportive Treatment and Antibiotics for Mild Pediatric Pneumonia

Status: Completed

Condition: Pneumonia

Interventions: Participants will be randomized to receive oral amoxicillin for a standard course (7 days)

Date: 2023-02-03

A Phase 1, First-in-human Study of VX-668

Status: Completed

Condition: Alpha-1 Antitrypsin Deficiency

Interventions: Suspension for oral administration.

Date: 2023-02-03